|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / August 2008 / August 25, 2008 Indian-origin researchers aggressive cocktail shows promise for drug-resistant TB cure |
More than two glasses of wine a day can cause heart trouble for women
Drug based on hormone melatonin offers effective jet lag treatment
Lining small intestines portion treats obesity, normalises glucose metabolism in rats
Extract of the plant cats claw may harbour dengue cure
A plant from the Amazon region called the cats claw has been found to be effective in combating dengue. ANI
Yeast studies provide clue about controlling cholesterol levels
Johns Hopkins researchers say that they have gained significant insights into the mechanism whereby a single-celled fungus regulates its version of cholesterol. ANI
Stress-related disorders deteriorates brains memory processing ability
Using functional MRI (fMRI), a researcher team, which was led by an Indian-origin scientist, has found that patients suffering from stress-related psychiatric disorders have impaired wiring in the area of the brain behind suppressing memory. ANI
An Indian-origin researchers in the U.S. says that a cure for drug-resistant tuberculosis (TB) is possible with a combination of at least five drugs.
London, August 25 : An Indian-origin researchers in the U.S. says that a cure for drug-resistant tuberculosis (TB) is possible with a combination of at least five drugs.
Dr. Salmaan Keshavjee of Harvard Medical School in the US carried out a trial with 600 patients in Russia, about five per cent of whom had extensively drug-resistant TB.
His team gave each patient an individually tailored treatment programme on the basis of the strain they had.
The researcher said that the aim was to provide at least five drugs to which that particular patient's strain of TB was susceptible.
He said that about half of the patients with extensively drug-resistant TB, and 67 per cent with multi-drug resistant TB had treatment cure or completion.
"Aggressive management of this infectious disease is feasible and can prevent high mortality rates and further transmission of drug-resistant strains of TB," the BBC quoted Dr. Keshavjee as saying.
Health experts in the UK hailed this research as good news, but insisted that it would require a lot of resources.
Dr John Moore-Gillon, a spokesperson for the British Lung Foundation, said: "The reason we have the problem is inadequate control of TB. This treatment is extremely labour and resource intensive and has to be done within extremely well structured TB programmes. It's a very important paper showing it's possible to deal with XDR-TB but it's very expensive."
He added that treating multi-drug resistant TB could cost tens of thousands, and the cost of treating extensively drug-resistant TB could be much more than that.
The study has been reported in the journal The Lancet.
ANI
